Iranian Red Crescent Medical Journal

Published by: Kowsar

Eligibility Assessment for Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients; Evaluating Barriers for Implementation

Hormoz Ayromlou 1 , Hassan Soleimanpour 2 , Mehdi Farhoudi 1 , Aliakbar Taheraghdam , Elyar Sadeghi Hokmabadi 1 , * , Rouzbeh Rajaei Ghafouri 2 , Mehdi Najafi Nashali 1 , Ehsan Sharifipour 1 , Somayeh Mostafaei 1 and Davar Altafi 1
Authors Information
1 Department of Neurology, Tabriz University of Medical Sciences, Tabriz, IR Iran
2 Department of Emergency, Tabriz University of Medical Sciences, Tabriz, IR Iran
Article information
  • Iranian Red Crescent Medical Journal: May 5, 2014, 16 (5); e11284
  • Published Online: May 5, 2014
  • Article Type: Research Article
  • Received: April 20, 2013
  • Accepted: April 29, 2013
  • DOI: 10.5812/ircmj.11284

To Cite: Ayromlou H, Soleimanpour H, Farhoudi M, Taheraghdam A, Sadeghi Hokmabadi E, et al. Eligibility Assessment for Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients; Evaluating Barriers for Implementation, Iran Red Crescent Med J. 2014 ; 16(5):e11284. doi: 10.5812/ircmj.11284.

Copyright © 2014, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussions
  • 1. Menken M, Munsat TL, Toole JF. The global burden of disease study: implications for neurology. Arch Neurol. 2000; 57(3): 418-20[PubMed]
  • 2. WHo . The global burden of disease. 2004;
  • 3. Jauch EC, Cucchiara B, Adeoye O, Meurer W, Brice J, Chan YY, et al. Part 11: adult stroke: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010; 122(18 Suppl 3)-28[DOI][PubMed]
  • 4. O'Rourke KE, Walsh CD, Kelly PJ. Safety and efficacy of IV-TPA for ischaemic stroke in clinical practice--a Bayesian analysis. Cerebrovasc Dis. 2009; 28(6): 572-81[DOI][PubMed]
  • 5. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004; 363(9411): 768-74[DOI][PubMed]
  • 6. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010; 375(9727): 1695-703[DOI][PubMed]
  • 7. Hosseini AA, Sobhani-Rad D, Ghandehari K, Benamer HT. Frequency and clinical patterns of stroke in Iran - Systematic and critical review. BMC Neurol. 2010; 10: 72[DOI][PubMed]
  • 8. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006; 367(9524): 1747-57[DOI][PubMed]
  • 9. Suwanwela NC, Phanthumchinda K, Likitjaroen Y. Thrombolytic therapy in acute ischemic stroke in Asia: The first prospective evaluation. Clin Neurol Neurosurg. 2006; 108(6): 549-52[DOI][PubMed]
  • 10. Ghandehari K, Zahed AP, Taheri M, Abbasi M, Gorjestani S, Ahmadi AM, et al. Estimation of Iranian stroke patients eligible for intravenous thrombolysis with tPA. Int J Stroke. 2009; 4(4): 236[DOI][PubMed]
  • 11. Nguyen TH, Truong AL, Ngo MB, Bui CT, Dinh QV, Doan TC, et al. Patients with thrombolysed stroke in Vietnam have an excellent outcome: results from the Vietnam Thrombolysis Registry. Eur J Neurol. 2010; 17(9): 1188-92[DOI][PubMed]
  • 12. De Silva DA, Yassin N, Toh AJ, Lim DJ, Wong WX, Woon FP, et al. Timing of arrival to a tertiary hospital after acute ischaemic stroke - A follow-up survey 5 years later. Ann Acad Med Singapore. 2010; 39(7): 513-5[PubMed]
  • 13. Durai Pandian J, Padma V, Vijaya P, Sylaja PN, Murthy JM. Stroke and thrombolysis in developing countries. Int J Stroke. 2007; 2(1): 17-26[DOI][PubMed]
  • 14. Wasay M, Barohi H, Malik A, Yousuf A, Awan S, Kamal AK. Utilization and outcome of thrombolytic therapy for acute stroke in Pakistan. Neurol Sci. 2010; 31(2): 223-5[DOI][PubMed]
  • 15. Naess H, Waje-Andreassen U, Brogger J, Thomassen L. [Patients with acute cerebral infarction admitted to stroke unit]. Tidsskr Nor Laegeforen. 2011; 131(8): 814-8[DOI][PubMed]
  • 16. Sung SF, Ong CT, Wu CS, Hsu YC, Su YH. Increased use of thrombolytic therapy and shortening of in-hospital delays following acute ischemic stroke: experience on the establishment of a primary stroke center at a community hospital. Acta Neurol Taiwan. 2010; 19(4): 246-52[PubMed]
  • 17. Sharma SR, Sharma N. Hyperacute thrombolysis with recombinant tissue plasminogen activator of acute ischemic stroke: feasibility and effectivity from an Indian perspective. Ann Indian Acad Neurol. 2008; 11(4): 221-4[DOI][PubMed]
  • 18. Hatcher MA, Starr JA. Role of tissue plasminogen activator in acute ischemic stroke. Ann Pharmacother. 2011; 45(3): 364-71[DOI][PubMed]
  • 19. Padma MV, Singh MB, Bhatia R, Srivastava A, Tripathi M, Shukla G, et al. Hyperacute thrombolysis with IV rtPA of acute ischemic stroke: efficacy and safety profile of 54 patients at a tertiary referral center in a developing country. Neurol India. 2007; 55(1): 46-9[PubMed]
  • 20. Nandigam K, Narayan SK, Elangovan S, Dutta TK, Sethuraman KR, Das AK. Feasibility of acute thrombolytic therapy for stroke. Neurol India. 2003; 51(4): 470-3[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments